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Abstract
Objective: The present study was undertaken to characterize the remodeling phenotype of human adipose tissue (AT)
macrophages (ATM) and to analyze their paracrine effects on AT progenitor cells.
Research Design and Methods: The phenotype of ATM, immunoselected from subcutaneous (Sc) AT originating from
subjects with wide range of body mass index and from paired biopsies of Sc and omental (Om) AT from obese subjects, was
studied by gene expression analysis in the native and activated states. The paracrine effects of ScATM on the phenotype of
human ScAT progenitor cells (CD34
+CD31
2) were investigated.
Results: Two main ATM phenotypes were distinguished based on gene expression profiles. For ScAT-derived ATM, obesity
and adipocyte-derived factors favored a pro-fibrotic/remodeling phenotype whereas the OmAT location and hypoxic
culture conditions favored a pro-angiogenic phenotype. Treatment of native human ScAT progenitor cells with ScATM-
conditioned media induced the appearance of myofibroblast-like cells as shown by expression of both a-SMA and the
transcription factor SNAIL, an effect mimicked by TGFb1 and activinA. Immunohistochemical analyses showed the presence
of double positive a-SMA and CD34 cells in the stroma of human ScAT. Moreover, the mRNA levels of SNAIL and SLUG in
ScAT progenitor cells were higher in obese compared with lean subjects.
Conclusions: Human ATM exhibit distinct pro-angiogenic and matrix remodeling/fibrotic phenotypes according to the
adiposity and the location of AT, that may be related to AT microenvironment including hypoxia and adipokines. Moreover,
human ScAT progenitor cells have been identified as target cells for ScATM-derived TGFb and as a potential source of
fibrosis through their induction of myofibroblast-like cells.
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Introduction
Excessive development of adipose tissue (AT) in obesity is
characterized by an accumulation of immune cells [1–4]. In
several models of murine obesity, the dynamic phase of AT growth
is associated with monocyte recruitment. Adipose tissue macro-
phages (ATM) originating from these newly recruited monocytes
showed a marked inflammatory phenotype in comparison to
resident ATM. Such a subset has been involved in the
establishment of the systemic low grade inflammation seen in
obesity and insulin resistance [1,2,4–6]. Much less is known about
the origin, phenotypes and function of macrophages in human
AT. Human ATM (hATM) have been described to be less
polarized, which may be considered as an index of chronic
inflammation [7–9]. Indeed, hATM expressed both pro- and anti-
inflammatory markers and the lymphatic vessel endothelial
hyaluronan receptor 1 (LYVE-1), a specific marker of macro-
phages involved in tumor growth and wound healing, as well as in
mouse AT angiogenesis [10,11]. In addition, hATM-conditioned
media stimulated AT-derived endothelial cell migration and
organization in capillary-like structures [8]. Interestingly, hATM
also expressed and secreted matrix metalloproteinase 9 (MMP-9)
[8]. MMP-9 is not only a key enzyme involved in angiogenesis
[8,12] but is also responsible for the proteolytic activation of latent
transforming growth factor beta (TGFb) [13], itself implicated in
the development of fibrosis [14]. Indeed, TGFb is known to
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blasts, via the enhanced expression of several developmental
transcription factors, including Snail and Slug [15,16]. In obese
mice models, Strissel et al. reported, a widespread deposition of
collagen that coincided with adipocyte death and macrophage
infiltration [17]. More recently, data in humans confirmed that fat
mass extension was correlated with collagen deposition and fibrosis
within AT, leading to systemic metabolic disturbances [18–20].
The number of ATM and their phenotype and location within the
AT appeared to be closely related to the foci of fibrosis [20].
Interestingly, large scale transcriptomic analyses of AT from obese
humans, together with immunohistochemical analysis and in vitro
approaches, have shown that inflammatory (i.e, LPS-stimulated)
monocyte-derived macrophages induced phenotypic alterations of
human AT progenitor cells that resulted in excessive synthesis of
extracellular matrix components [21,22]. Furthermore, we and
others have shown that factors secreted by hATM inhibited the
adipogenesis of human AT progenitor cells either directly or
through the enhanced expression of a TGFb family member,
INBHA/activinA [8,23,24]. The fate of these AT progenitor cells
arrested by hATM-derived factors remains to be established.
The present study was undertaken to 1) investigate the influence
of adiposity, AT location (subcutaneous versus omental) and its
microenvironment on the phenotype of native hATM in terms of
angiogenic and matrix remodeling/pro-fibrotic factors and 2)
analyze the phenotype of native human AT progenitor cells
arrested by macrophage-derived factors.
Materials and Methods
Materials
Chemicals were from Sigma (Saint-Quentin Fallavier, France).
Collagenase type 1 was from Worthington Biochemical Corpora-
tion (Lakewood, USA). Selection kits for CD34
+ and CD14
+ cells
were from StemCell Technologies (Grenoble, France). Culture
media were from Promocell (Heidelberg, Germany). Primary
antibodies for immunochemistry were from Sigma (mouse
monoclonal anti-a-SMA/clone 1A4, Saint-Quentin Fallavier,
France), Epitomics (rabbit monoclonal anti-CD34, Euromedex,
Mundolsheimm, France), R&D Systems (mouse monoclonal anti-
TGFb (clone 1D11) and anti-activinA, Lille, France) and Dako
(mouse IgG1 and mouse monoclonal anti-smooth muscle myosin
heavy chain (clone SMM-1), Trappes, France) and the secondary
antibodies from Invitrogen (Cergy-Pontoise, France).
Preparation of human AT stroma vascular fraction (SVF)
and mature adipocytes
Human subcutaneous (Sc) AT were obtained from healthy
women, undergoing elective surgery for fat removal for aesthetic
purposes (mean age 43.861.3 years, mean body mass index (BMI)
27.760.6 kg/m
2). Human omental (Om) and subcutaneous (Sc)
AT were obtained from a group of obese non-diabetic patients
undergoing bariatric surgery (22 paired biopsies; 20 women/2
men; mean age 41.362.5 years (from 26 to 61 years), mean BMI
43.961.4 kg/m
2 (from 37 to 59 kg/m
2), and mean waist-
circumference 124.562.7 cm (from 109 to 151 cm). All patients
gave their informed consent. Based on medical information, the
mean time since obesity has been diagnosed was 19.762.3 years,
their weights were stable for at least three months before surgery
and 1 patient was identified as pre-diabetic, 3 had hypercholes-
terolemia, 1 triglyceridemia and 6 patients were hypertensive. The
protocol for this study was approved by the Institutional Research
Board of INSERM and Toulouse University Hospital. The AT
was immediately processed after removal and digested using
collagenase (250 U/mL in phosphate-buffered saline (PBS), 2%
bovine serum albumin (BSA), pH 7.4, volume/volume) for 30 min
at 37uC under constant shaking. After a brief centrifugation
(100 g, 30 s, room temperature (RT)), adipocytes were recovered
and washed in order to be either plated in fibrin gels [3] with basal
medium (i.e. Endothelial Cell Basal Medium (ECBM)/0.1% BSA/
0.05 mg/ml gentamycin) for 24 h to collect conditioned media
(CM), or lyzed in Qiazol lysis reagent (volume/volume, Qiagen,
Courtaboeuf, France) for lipid and RNA extraction. Adipocyte-
CM were collected, centrifuged (20 000 g, 3 min, RT) and stored
at 220uC until further use. After another centrifugation (300 g,
10 min, RT), the pellet containing the SVF was resuspended in
erythrocyte lysis buffer (155 mmol/L NH4Cl; 5.7 mmol/L
K2HPO4; 0.1 mmol/L EDTA (ethylenediaminetetraacid);
pH 7.3) for 10 min. Finally, and after successive filtrations through
100-, 70- and 40- mm sieves, the SVF cells were resuspended in
PBS/2% fetal calf serum (FCS) and used to separate the different
cell types.
Isolation and culture conditions of the cells from human
AT SVF
CD34
+/CD31
2, defined as AT progenitors cells, CD34
+/
CD31
+, defined as endothelial cells, and CD34
2/CD14
+ cells,
defined as ATM, were isolated from ScAT SVF using an
immunoselection/depletion protocol as previously described
[3,25,26].
Freshly isolated CD34
2/CD14
+ cells (i.e, ATM), were either
then lyzed in RLT lysis buffer (Qiagen, Courtaboeuf, France) and
stored at 220uC for further mRNA extraction or cultured
(250 000 cells/cm
2) for 24 h (i) in basal medium under a normoxic
or hypoxic (1% O2) atmosphere or (ii) treated with mature
adipocyte-CM. Normoxic 24 h-basal media conditioned by ATM
were collected, centrifuged (20 000 g, 3 min, RT) and stored at
220uC until further use.
Freshly isolated CD34
+/CD31
2 AT progenitors cells were
either lyzed in RLT lysis buffer (Qiagen, Courtaboeuf, France)
and stored at 220uC for further mRNA extraction or cultured
(10 000 cells/cm
2) in ECBM/10%FCS until confluence. AT
progenitor cells were then trypsinized (TrypLE Express, Gibco/
Invitrogen, Cergy Pontoise, France), plated at 80 000 cells/cm
2
and left for a few hours to recover. Prior to use, progenitor cells
were washed to eliminate FCS and left overnight in basal medium.
Medium was then replaced for 24 h or 48 h (gene expression
analysis) or 48 h (immunocytochemistry) by (i) control basal
medium, (ii) ATM-CM, (iii) basal medium containing human
recombinant TGFb1 (5 ng/ml, eBioscience, Paris, France) or (iv)
basal medium containing human recombinant activinA (100 ng/
ml, Peprotech, Neuilly sur Seine, France).
Freshly isolated CD34
+/CD31
+ endothelial cells were lysed in
RLT lysis buffer and stored at 220uC for further mRNA
extraction.
Human multipotent adipose-derived stem (hMADS) cell
culture and activinA treatment
hMADS cells were obtained from the stroma of human AT as
described previously [27]. The cells were isolated from the pubic
region fat pad of a 4-month old (hMADS3) male donor. Cells were
plated at 22 000 cell/cm
2 in proliferation medium (DMEM (low
glucose), 10% FCS, 100 U/ml penicillin and streptomycin). After
24 h, the proliferation medium was removed and the cells
maintained in DMEM containing insulin (5 mg/ml), and transfer-
rin (10 mg/ml), supplemented or not with 100 ng activinA/ml
(Peprotech). RNAs were extracted after a further 24 h and 48 h.
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Total RNA was extracted from AT-derived ATM, endothelial
cells, progenitor cells and mature adipocytes using an RNeasy kit
(Qiagen, Courtaboeuf, France). The RNA concentration was
determined fluorimetrically (Ribogreen, Invitrogen, Cergy-Pon-
toise, France) and the RNA was reverse-transcribed using the
‘‘Superscript II’’ kit (Invitrogen, Cergy-Pontoise, France). Reverse
transcription was also carried out on RNA samples without the
superscript enzymetoensuretheabsence ofcontaminating genomic
DNA. Primers for interleukin 6 (IL-6), interleukin 10 (IL-10),
transforming growth factor b (TGFb1), monocyte chemotactic
protein 1 (MCP-1), matrix metalloproteinase 2 (MMP-2), matrix
metalloproteinase 9 (MMP-9), lymphatic vessel endothelial hyalur-
onan receptor 1 (LYVE-1), hypoxia-inducible factor 1a (HIF-1a),
hypoxia-inducible factor 2a (HIF-2a/EPAS1), vascular endothelial
growth factor (VEGFA), Snail (snail1), Slug (snail2), inhibinA
(activinA), TGFb receptor 1 (ALK-5), Smad2, Smad3, fibronectin
(fibronectin 1), activinA receptor type I (ACVR1A/ALK-2) and
plasminogen activator inhibitor-1 (PAI-1) were from Applied
Biosystems (Courtaboeuf, France) (Hs00174131_m1, Hs00174086_
m1, Hs00171257_m1, Hs00234140_m1, Hs00234422_m1, Hs00
234579_m1, Hs00272659_m1, Hs00156153_m1, Hs00181674_
m1, Hs00173626_m1, Hs00195591_m1, Hs00161904_m1, Hs00
170103_m1, Hs00610319_m1, Hs00183425_m1, Hs00969210_
m1, Hs00365058_m1, Hs00153836_m1, Hs00167155_m1, respec-
tively). The amplification reaction was done induplicateon15 ngof
the cDNA samples in a final volume of 20 mL in 96-well reaction
plates (Applied Biosystems) in a GeneAmp 7500 detection system.
All reactions were carried out under the same conditions: 50uC for
2 min, 95uC for 10 min, 40 cycles of 95uC for 15 sec and 60uC for
1 min. Resultswereanalyzedwith the GeneAmp7500 softwareand
all the values were normalized to the levels of 18S rRNA (Applied
Biosystems, VIC/TAMRA probe, part nu4310893E).
For hMADS cells, total RNA was extracted using an RNeasy kit
(Qiagen, Courtaboeuf, France) and the RT-PCR analysis was
done using superscript II reverse transcriptase (Invitrogen, Cergy-
Pontoise, France) according to the manufacturer’s instructions.
Real-time PCR assays were run on an ABI Prism 7000 real-time
PCR machine (PerkinElmer Life Sciences). Normalization was
done using the geometric averages of the housekeeping genes,
G6PDH (glucose-6-phosphate dehydrogenase), POLR2A (poly-
merase RNA II), and TBP (TATA box binding protein) and
quantification using the comparative-DCt method. The primer
sequences used for quantitative PCR are detailed in Table S1.
Immunocytochemistry and immunohistochemistry
AT progenitor cells treated for 48 h with TGFb1, ATM-CM or
ATM-CM plus neutralizing antibodies (1 h pre-incubation of
ATM-CM with anti-TGFb 1 mg/mL, anti-activinA 1 mg/mL or
both) were fixed (30 min, paraformaldehyde 4%, RT), washed and
incubated for 1 h in PBS/2% BSA/0.1%Triton followed by an
overnight incubation with a-smooth muscle actin (SMA) or
smooth muscle myosin mouse monoclonal antibody (1/250 and
1/100 respectively). After washing (1 h, PBS/0.2% Tween), cells
were incubated for 90 min with the corresponding fluorescence-
labeled second antibody (goat anti-mouse coupled to AlexaFluor
546, 1/250). Cells were washed and incubated for 10 min with
10 mg/mL Hoechst 33242 (Invitrogen, Cergy-Pontoise, France) to
stain nuclei and washed again before direct observation with a
fluorescence microscope (Nikon) and representative images were
recorded (NIS-Elements BR software). Mouse monoclonal IgG1
was used as a negative control. The number of a-SMA
+ foci in the
whole well (total magnification 620) was counted for analysis. To
analyze the effects of neutralizing antibodies, a-SMA
+ foci were
counted on 3 to 4 standardized fields (total magnification610) and
normalized to nuclei number (Image J 1.44p software, NIH, USA).
Pieces of ScAT (2–3 mm
3) were fixed in neutral buffered 4%
(w/v) paraformaldehyde (1 h, RT), blocked in PBS/3% BSA
(30 min, RT), and incubated in PBS/0.1% BSA/0.2% Triton/
0.05% Tween with primary antibodies overnight at 4uC (i.e,
CD34 1/100 and a-SMA 1/80). After washing, the ScAT samples
were incubated for 1 h with secondary antibodies (goat anti-mouse
or goat anti-rabbit coupled to AlexaFluor 546 or 488, 1/250).
Nuclei were stained with Hoechst 33242. Fluorescence analysis
was carried out utilizing a Nikon inverted Eclipse TE300
microscope and NIS-Elements BR software.
Statistical analysis
Values are given as mean 6 SE mean for (n) separate
experiments. Comparisons between groups were analyzed either
by unpaired (Mann-Whitney) or paired (Wilcoxon or Student) tests
or one-way ANOVA (parametric or non parametric, for repeated
measure or not), followed by a Dunn’s multiple comparison test,
respectively (Prism 4, GraphPad Software, USA). Differences were
considered significant when P,0.05.
Results
Impact of obesity and AT location on the remodeling
phenotypes of native human AT macrophages
The expression of several genes involved in angiogenesis and
matrix remodeling/fibrosis (IL-10, IL-6, TGFb1, MCP-1, MMP-2
and -9, VEGFA and LYVE-1) were analyzed by real-time PCR in
human native ATM (CD34
2/CD14
+) immunoselected from the
ScAT of non-obese and obese individuals. As shown in the figure 1,
the levels of expression of TGFb1 as well as MCP-1, MMP-2, LYVE-
1 and VEGFA were markedly higher whereas MMP-9 transcript
levels were lower in the ATM isolated from the obese compared to
the non-obese group. Similar analyses on native ATM isolated from
paired ScAT and OmAT biopsies of obese individuals showed that
OmATM expressed more angiogenic markers than ScATM as
shown by the higher levels of VEGFA, LYVE-1 and IL-6 (Fig. 2A). In
contrast, ScATM showed higher expression of factors involved in
matrix remodeling and fibrosis suchas TGFb1 as well asMCP-1 and
MMPs (2 and 9). Higher levels of both HIF-1a and HIF-2a
transcripts were observed in OmATM versus ScATM (Fig. 2B).
Impact of hypoxia and adipokines on the remodeling
phenotypes of native human AT macrophages
Human ScATM were maintained under normoxic or hypoxic
culture conditions (1% O2) or in the presence or absence of
conditioned media from human ScAT mature adipocyte (adipo-
cyte-CM). Real-time PCR analysis revealed distinct gene regulation
profiles depending on the culture conditions. The levels of
expression of both angiogenic markers VEGFA and LYVE-1 were
up-regulated under low oxygen tension whereas those of the factors
involved in matrix remodeling and fibrosis including TGFb1 but
also MCP-1 and MMP-9 were up-regulated by adipocyte-derived
secretions (Fig. 3A and 3B). To note, MMP-2 expression was found
to be decreased in this condition. The expression level of IL-6 was
increased in both culture conditions whereas the one of IL-10 was
up-regulated with only adipocyte-CM.
The human native AT progenitor cells: a cell target of
TGFb1
The expression of several key components of the TGFb
signaling pathway, including TGFb receptor 1 (TGFbRI/ALK5),
Pro-fibrotic Macrophages in Adipose Tissue
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31274Figure 1. Obesity status affects the remodeling phenotype of human subcutaneous AT macrophages. ATM were immunoselected from
subcutaneous AT from 18 non obese individuals (Nob, mean BMI 25.460.6 kg/m
2) and 22 obese individuals (Ob, mean BMI 43.961.4 kg/m
2) and the
transcript levels of angiogenic and matrix remodeling/fibrotic factors were determined by real-time PCR analyses. Values are means 6 SEM (AU,
arbitrary unit). * P,0.05, *** P,0.001 vs Nob. IL, interleukin; MCP-1, monocyte chemotactic protein 1; MMP, matrix metalloproteinase; VEGF, vascular
endothelial growth factor; LYVE-1, lymphatic vessel endothelial hyaluronan receptor 1.
doi:10.1371/journal.pone.0031274.g001
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FIBRONECTIN and PAI-1, were analyzed by real-time PCR on
isolated human ScAT native mature adipocytes, endothelial cells
(CD34
+/CD31
+), progenitor cells (CD34
+/CD31
2) and ATM
(CD34
2/CD14
+). As shown in figure 4, TGFbRI as well as
ACVR1, SMAD3, FIBRONECTIN and PAI-1 transcript levels were
higher in native human AT progenitor cells compared with
mature adipocytes, endothelial cells and/or ATM.
Induction of a myofibroblast-like phenotype in human
native AT progenitor cells by ATM-conditioned media
and TGFb family members
ScAT progenitor cells were treated either with ScATM-
conditioned media (ScATM-CM) or TGFb1 for 48 h and the
number of cells expressing the myofibroblast marker a-SMA was
analyzed by immunocytochemistry. As shown in figure 5, under
control culture conditions, the vast majority of ScAT progenitor
cells exhibited a diffuse a-SMA labelling and few cells containing
specific stress fibers were identified (2564 a-SMA
+ foci/well).
Treatment with TGFb1 markedly increased a-SMA
+ stress fiber
foci with no changes in total cell number (estimated by nuclei
counts, data not shown). ATM-CM treatment was also associated
with an increase in a-SMA
+ stress fiber foci, although with a lower
extent (58614 a-SMA
+ foci/well) with no changes in total cell
number (data not shown). Interestingly, ATM secretions also
induced the appearance of stellate-shaped myofibroblast (right
panel), a distinct morphological state of myofibroblasts. In parallel,
the expression of myofibroblast transcription factors, SNAIL and
SLUG, were analyzed by real-time PCR as well as the expression of
INHBA/activinA, a member of TGFb family. As shown in
figures 6A and 6B, treatment of ScAT progenitor cells with either
TGFb1 or ScATM-CM markedly up-regulated SNAIL and
INHBA/activinA transcripts but had no effect on SLUG expression.
Furthermore, treatment of native ScAT progenitor cells with
activinA up-regulated SNAIL expression after 24 or 48 h of
treatment (3.2 fold increase, n=3, P,0.05) suggesting that the up-
regulation of ActivinA expression by TGFb treatment may
contribute to the acquisition of the myofibroblast-like phenotype
by AT progenitor cells. Indeed, treatment of AT progenitor cells
with ScATM-CM in the presence of neutralizing antibodies
directed against TGFb1 and ActivinA, led to an inhibition of
ScATM-CM effect on the number of a-SMA
+ foci (Fig. 6C and D)
although the inhibitory effect was more marked with the anti-
TGFb antibodies (3.7 fold decrease, n=3, P,0.05) compared to
activinA antibodies. To rule out the possibility of contaminations
with smooth muscle cells, immunocytochemistry assays using anti-
smooth muscle myosin antibody on ATM-CM treated AT
progenitor cells was performed and produced no detectable signal
Figure 2. AT location affects the remodeling phenotype of human AT macrophages in obese individuals. A, Transcript levels of
angiogenic and matrix remodeling/fibrotic factors were determined by real-time PCR analyses of ATM immunoselected from paired biopsies of
subcutaneous (Sc) and omental AT (Om). Results are expressed as fold differences between Om and Sc and are means 6 SEM (n=22 subjects, mean
BMI 43.961.4 kg/m
2). Open bars: genes up-regulated, and solid bars: genes down-regulated, in OmATM vs ScATM. B, Transcript levels of HIF-1a and
-2a determined by real-time PCR analyses of ScATM and OmATM. Values are means 6 SEM (AU, arbitrary unit) of the 22 paired biopsies. * P,0.05 and
*** P,0.001 vs Om.
doi:10.1371/journal.pone.0031274.g002
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ActivinA on AT progenitor cells, the human AT progenitor cell
line, hMADS, was used. Treatment of hMADS cells with ActivinA
led to a marked up-regulation of a-SMA expression associated with
an up-regulation of SNAIL but no effect on SLUG mRNA levels
(Fig. 6E).
Evidence of an increase in AT myofibroblast-like
progenitor cells with obesity
Immunohistochemistry was carried out on human ScAT using
CD34 and a-SMA antibodies. Distinct CD34
+ as well as a-SMA
+
cell subsets were observed. Co-labeled CD34
+/a-SMA
+ cells were
identified in the AT stroma (Fig. 7A) whereas a-SMA
+ but CD34
2
cells, were found at perivascular location, most probably
corresponding to pericytes (Fig. 7B). The expression of both
SNAIL and SLUG were determined in native AT progenitor cells
isolated from ScAT by real time PCR analyses. Both SNAIL and
SLUG transcripts were found to be higher in native AT progenitor
cells from obese compared with non-obese individuals (Fig. 7C).
Discussion
Extensive AT growth has been recently associated with
increased fibrosis in rodents as well as in humans [1–
3,17,19,20,28]. We previously showed that ATM from the ScAT
of lean and overweight subjects exhibited a phenotype character-
ized by the specific expression of MMP-9 and pro-angiogenic
properties [8]. The present study extends these data to ATM from
obese individuals in agreement with recent literature [9,29].
Moreover, based on gene expression profiles determined on native
ATM, we could distinguish two main phenotypes related to
angiogenesis in OmAT and to matrix remodeling/fibrosis in
ScAT. Indeed, OmATM compared with ScATM from obese
patients had higher transcript levels of genes involved in
angiogenesis, including IL-6, VEGFA and LYVE-1, together with
higher expression of HIF-1a and HIF-2a. Our previous study
reported higher expression of hypoxia-related genes in mature
adipocytes from OmAT compared with ScAT, including HIF-1a
and VEGFA suggesting that hypoxia-related events are more likely
Figure 3. Hypoxia and mature adipocyte-derived factors affect the remodeling phenotype of human subcutaneous AT
macrophages. Transcript levels of angiogenic and matrix remodeling/fibrotic factors were determined by real-time PCR analyses on ScATM
cultured for 24 h (A) in hypoxic conditions (1% O2, n=5) and (B) in mature subcutaneous adipocyte-conditioned media (CM, n=5). Values, expressed
as a percentage of the control, are means 6 SEM. * P,0.05 and ** P,0.01 vs control conditions.
doi:10.1371/journal.pone.0031274.g003
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hypothesis, the present data show that hypoxic culture conditions
mimicked the OmATM phenotype in ScATM, i.e. up-regulation
of IL-6, VEGFA and LYVE-1. Interestingly, vascular network and
endothelial cell number were found to be higher in OmAT versus
ScAT [30]. Compared to OmATM, ScATM were characterized
by higher expression of matrix remodeling/fibrosis-related genes,
including TGFb1 as well as MMP-2 and -9. The MMPs, and more
particularly MMP-9, play a key role in the proteolytic activation of
latent TGFb1 [13], itself involved in extracellular matrix
homeostasis [31–33] and fibrosis [14]. Secretions from mature
subcutaneous adipocytes favored the appearance of a matrix
remodeling/fibrosis-related phenotype in ScATM, as shown by
the increased expression of TGFb1 and MMP-9. Unexpectedly,
Figure 4. Components of TGFb-signaling pathway in human subcutaneous AT cells. TGFb R1 (ALK5) (A), activinA R1 (ACVR1A/ALK2) (B),
SMAD2 (C), SMAD3 (D), FIBRONECTIN (E) and PAI-1 (F) transcript levels were determined by real-time PCR in ScAT mature adipocytes (Adip), endothelial
cells (EC), progenitor cells (Prog) and ATM. Values are means 6 SEM (AU, arbitrary units) of 5 to 27 independent. * P,0.05, ** P,0.01 and *** P,0.001
between cell types.
doi:10.1371/journal.pone.0031274.g004
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and 9 are functionally related, the composition of their promoter is
quite different leading to specific gene regulation [34]. Taken
together, the results suggest that the location-specific and
adiposity-dependent microenvironment of AT among them
oxygen tension and adipokines, modulate the phenotype of
ATM towards a matrix remodeling/fibrosis-related phenotype in
ScAT and angiogenesis in OmAT.
Recently, total fibrosis has been described to be more abundant
in ScAT versus OmAT in humans [19]. Taken into account the
pivotal role of TGFb1 in fibrosis and since TGFb1 expression in
ATM was higher in obese than non-obese on one hand and in the
other in ScAT versus OmAT, we hypothesize a role of ATM in
the genesis of ScAT fibrosis. First, the AT potential cell targets of
TGFb1 were analyzed. Human native AT progenitor cells (i.e,
CD34
+/CD31
2 cells) in comparison with mature adipocytes,
endothelial cells (i.e, CD34
+/CD31
+ cells) and ATM, expressed
higher levels of the key components of the TGFb family signaling
pathway, including TGFbR1 (ALK5), ACVR1A (ALK2) and SMAD3,
as well as specific target genes including FIBRONECTIN and PAI-
1. Therefore, among the distinct cell populations constituting
human AT, progenitor cells appear to be the main cell target of
TGFb. TGFb1 treatment of AT progenitor cells led to an increase
in aSMA
+ stress fiber foci associated with an up-regulation of both
INHBA/activinA and the transcription factor SNAIL, hallmark of
myofibroblast [35,36]. Such an effect was mimicked by condi-
tioned media from ScATM. To note, in addition to the increase in
a-SMA
+ stress fiber foci, ScATM-conditioned media treatment led
to the appareance of stellate-shaped myofibroblasts. Although
additional experiments will be required to clearly characterize the
myofibroblasts arising from the treatment with ScATM, it has
been suggested that myofibroblasts might exhibit distinct cell
Figure 5. TGFb1 and subcutaneous AT macrophage-conditioned media induce a-SMA expression in human AT progenitor cells.
Representative photomicrograph of immunocytochemical staining for a-SMA (red) of ScAT progenitors cells (n=4) cultured for 48 h with basal
medium (i.e, control), with TGFb1 (5 ng/ml, n=4, upper panel) or with ScATM-CM (n=6, middle and lower panels). Nuclei were stained with Hoechst
33242 (blue). Magnification 620 and 640. White scale corresponds to 50 mm.
doi:10.1371/journal.pone.0031274.g005
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31274Figure 6. TGFb1 and subcutaneous AT macrophage-conditioned media induce a myofibroblast-like phenotype in human AT
progenitor cells. A and B, Transcript levels of SNAIL, SLUG and INHBA/activinA were determined by real-time PCR analyses in ScAT progenitor cells
treated for 24 h with basal medium (i.e, control, n=4 to 5), with TGFb1 (5 ng/ml, n=4) or with ScATM-CM (n=6). Results are expressed as percentage
of the control and are means 6 SEM. * P,0.05 and ** P,0.01 vs control media. C, Representative photomicrograph of immunocytochemical staining
for a-SMA (magnification 610) of ScAT progenitors cells (n=3) that were cultured for 48 h with ScATM-CM (n=5) in the presence or not of
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We have previously reported that CM from ScATM inhibit
adipogenesis [8] and increase the expression of INHBA/activinA in
native AT progenitor cells [24]. Treatment of native progenitor
cells with activinA was associated with increased expression of
SNAIL. Finally, when TGFb and to a lower extent activinA were
neutralizing antibodies directed against TGFb (1 mg/ml), activinA (1 mg/ml) or both (A+T, 1 mg/ml each). White scale corresponds to 50 mm. D,
Number of a-SMA
+ foci per 100 nuclei. Values are expressed as a percentage of ScATM-CM and are means 6 SEM. * P,0.05 vs ScATM-CM, n=3. E,
Transcript levels of SNAIL, SLUG and a-SMA were determined by real-time PCR analyses in hMADS treated or not with activinA (100 ng/ml) for 24 h
(n=4). Values are expressed as fold increase of the controland are means 6 SEM. * P,0.05 and *** P,0.001 vs control media.
doi:10.1371/journal.pone.0031274.g006
Figure 7. Obesity is associated with increased expression of myofibroblast markers in subcutaneous AT progenitor cells. A and B,
Representative photomicrograph of immunohistochemistry of whole ScAT staining: a-SMA (red), CD34 (green) and nuclei (Hoechst 33242/blue)
(n=9). White scale corresponds to 50 mm. C, SNAIL and SLUG transcript levels were determined by real-time PCR in immunoselected ScAT progenitor
cells from 7 non obese (Nob) and 8 obese (Ob) individuals. Values are means 6 SEM (AU, arbitrary units). * P,0.05 and ** P,0.01 vs Nob.
doi:10.1371/journal.pone.0031274.g007
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+ foci were
reduced. To clearly establish the specificity of activinA effect on
AT progenitor cells, treatments were performed on human AT
progenitor cell line, hMADS, since previous results showed that
ScATM treatment of hMADS led to an inhibition of adipogenesis
together with an up-regulation of activinA [24]. In the present
study, we show that activinA treatment of hMADS cells led to an
up-regulation of a-SMA and SNAIL expression. Taken together,
the present study shows that ATM-derived factors and most
specifically TGFb1 induced a myofibroblast-like phenotype of AT
progenitor cells. Such an effect may be mediated, at least in part,
through the induction of INHBA/activinA expression by the
progenitor cells.
a-SMA
+ cells were recently identified in situ in fibrotic foci of
ScAT from obese individuals [19]. We show that among a-SMA
+
cells present within human ScAT, some exhibited pericyte-like
characteristics, ie. negative for CD34 and in perivascular location.
Other a-SMA
+ were localized in the AT stroma and co-expressed
CD34, suggesting that such a cell subset might arise from AT
progenitor CD34
+/CD31
2 cells. Gene expression analysis of
native ScAT progenitor cells revealed that the expressions of both
SNAIL and SLUG were higher in obese compared with lean
individuals. Altogether, it is tempting to speculate that some
progenitor cells in ScAT from obese individuals are induced
towards a myofibroblast-like phenotype due to changes in the
microenvironment, especially the pro-fibrotic TGFb1-derived
human ScATM. However, additional studies are necessary to
clearly define the mechanisms involved in the induction of
myofibroblast phenotype including the signaling pathway as well
as the consequence of such an event.
In conclusion, the present results show that human native ATM
exhibit distinct phenotypes according to the location of the AT
and the degree of adiposity. These phenotypes might be linked to
the AT microenvironment including adipokines and hypoxia. In
human ScAT, ATM-derived secretions, including TGFb1,
promote the appearance of a myofibroblast-like phenotype of
human AT progenitor cells that may be mediated through the
induction of INHBA/activinA. In murine models, AT fibrosis has
been associated with physical constrains limiting adipocyte
hypertrophy [38]. Since AT native progenitor cells treated with
hATM-CM reduced their adipogenic capacity [8], one might
speculate that the reorientation of the human AT progenitor cells
into myofibroblasts-like cells indirectly contributes to a reduction
in adipocyte hyperplasia. Consequently both decreased adipocyte
hypertrophy and hyperplasia leading to reduced ScAT expand-
ability may promote ectopic fat deposition. Therefore TGFb
family members (i.e, TGFb1 and activinA) produced by ScATM
and AT progenitor cells represent interesting targets to improve
the storage capacity of ScAT.
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